BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 23077594)

  • 1. Determining Mycobacterium tuberculosis infection among BCG-immunised Ugandan children by T-SPOT.TB and tuberculin skin testing.
    Nkurunungi G; Lutangira JE; Lule SA; Akurut H; Kizindo R; Fitchett JR; Kizito D; Sebina I; Muhangi L; Webb EL; Cose S; Elliott AM
    PLoS One; 2012; 7(10):e47340. PubMed ID: 23077594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosing latent tuberculosis infection in haemodialysis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test?
    Soysal A; Toprak D; Koc M; Arikan H; Akoglu E; Bakir M
    Nephrol Dial Transplant; 2012 Apr; 27(4):1645-50. PubMed ID: 21931124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commercial interferon gamma release assays compared to the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection in childhood contacts in the Gambia.
    Adetifa IM; Ota MO; Jeffries DJ; Hammond A; Lugos MD; Donkor S; Patrick O; Adegbola RA; Hill PC
    Pediatr Infect Dis J; 2010 May; 29(5):439-43. PubMed ID: 20068506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
    O'Shea MK; Fletcher TE; Beeching NJ; Dedicoat M; Spence D; McShane H; Cunningham AF; Wilson D
    PLoS One; 2014; 9(5):e97366. PubMed ID: 24816576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Good Agreement between an Interferon Gamma Release Assay and Tuberculin Skin Tests in Testing for Latent Tuberculosis Infection among HIV-Infected Patients in Indonesia.
    Reviono R; Saptawati L; Redhono D; Suryawati B
    J Korean Med Sci; 2019 Oct; 34(40):e259. PubMed ID: 31625291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of Tuberculin Skin Test (TST) and T-SPOT.TB Tests for Diagnosis of Latent Tuberculosis Infection (LTBI) in HIV-infected Patients].
    Binay UD; Fincancı M; Fersan E; Karakeçili F
    Mikrobiyol Bul; 2019 Oct; 53(4):388-400. PubMed ID: 31709936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing tuberculin skin test and interferon γ release assay (T-SPOT.TB) to diagnose latent tuberculosis infection in household contacts.
    Lee HW; Lee YJ; Kim SJ; Park JS; Cho YJ; Yoon HI; Lee CT; Lee JH
    Korean J Intern Med; 2017 May; 32(3):486-496. PubMed ID: 28111432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relating Tuberculosis (TB) Contact Characteristics to QuantiFERON-TB-Gold and Tuberculin Skin Test Results in the Toronto Pediatric TB Clinic.
    Rose W; Read SE; Bitnun A; Rea E; Stephens D; Pongsamart W; Kitai I
    J Pediatric Infect Dis Soc; 2015 Jun; 4(2):96-103. PubMed ID: 26407408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculin skin testing and T-SPOT.TB in internationally adopted children.
    Spicer KB; Turner J; Wang SH; Koranyi K; Powell DA
    Pediatr Infect Dis J; 2015 Jun; 34(6):599-603. PubMed ID: 25973937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly discordant T cell responses in individuals with recent exposure to household tuberculosis.
    Hesseling AC; Mandalakas AM; Kirchner HL; Chegou NN; Marais BJ; Stanley K; Zhu X; Black G; Beyers N; Walzl G
    Thorax; 2009 Oct; 64(10):840-6. PubMed ID: 18682523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-γ response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection.
    Latorre I; Martínez-Lacasa X; Font R; Lacoma A; Puig J; Tural C; Lite J; Prat C; Cuchi E; Ausina V; Domínguez J
    BMC Infect Dis; 2010 Dec; 10():348. PubMed ID: 21143955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Stability of Resistance to Latent Mycobacterium tuberculosis Infection in Highly Exposed Tuberculosis Household Contacts in Kampala, Uganda.
    Stein CM; Nsereko M; Malone LL; Okware B; Kisingo H; Nalukwago S; Chervenak K; Mayanja-Kizza H; Hawn TR; Boom WH
    Clin Infect Dis; 2019 May; 68(10):1705-1712. PubMed ID: 30165605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.
    Yilmaz N; Zehra Aydin S; Inanc N; Karakurt S; Direskeneli H; Yavuz S
    Lupus; 2012 Apr; 21(5):491-5. PubMed ID: 22140142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borderline QuantiFERON results and the distinction between specific responses and test variability.
    Uzorka JW; Bossink AWJ; Franken WPJ; Thijsen SFT; Leyten EMS; van Haeften AC; Doornenbal G; Boonstra P; Ottenhoff THM; Arend SM
    Tuberculosis (Edinb); 2018 Jul; 111():102-108. PubMed ID: 30029893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
    Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
    Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial.
    Ruhwald M; Aggerbeck H; Gallardo RV; Hoff ST; Villate JI; Borregaard B; Martinez JA; Kromann I; Penas A; Anibarro LL; de Souza-Galvão ML; Sánchez F; Rodrigo-Pendás JÁ; Noguera-Julian A; Martínez-Lacasa X; Tuñez MV; Fernández VL; Millet JP; Moreno A; Cobos N; Miró JM; Roldan L; Orcau A; Andersen P; Caylá JA;
    Lancet Respir Med; 2017 Apr; 5(4):259-268. PubMed ID: 28159608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis.
    Simsek H; Alpar S; Ucar N; Aksu F; Ceyhan I; Gözalan A; Cesur S; Ertek M
    Jpn J Infect Dis; 2010 Mar; 63(2):99-102. PubMed ID: 20332570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of the tuberculin skin test and the T-SPOT.TB assay among students in a low-tuberculosis incidence setting.
    Talbot EA; Harland D; Wieland-Alter W; Burrer S; Adams LV
    J Am Coll Health; 2012; 60(1):94-6. PubMed ID: 22171735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.